I have spent some time looking at the competition Antigermix. Only 3 trials I could find all of which from Europe, one of which was a prototype device. The methodology wasn't strong and not contemporary. I cant find any data on safety to probes. UVC is known to cause degradation to plastics etc over time, cant imagine companies being too happy to recommend use without testing. NAN has spent a lot of RD on this. I even found an evaluation from a French Hospital system which questioned the evidence for use and declined to recommend the product in their hospital system. NAN seems a long way ahead on this front. The more I look into this product and its prospects the more I like it.
NAN Price at posting:
$1.36 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)